RecombiMAb antimouse/human VEGF-A- 25 mg and 1 more item
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0485293
- Awardee
- Bio X Cell
- Contracting organization
- University of Virginia
- Cumulative value
- $5,391
About this award
The University of Virginia awarded contract A207_PO-0485293 to Bio X Cell on September 26, 2026, with a cumulative contract value of $5,391.05. The contract calls for the delivery of RecombiMAb antimouse/human vascular endothelial growth factor-A (VEGF-A) in a 25-milligram quantity to Sahithi Mikkilineni, priced at $5,307.05 per unit.
The contract includes ancillary shipping and handling services via Federal Express, valued at $84.00. The performance location is Virginia. No specific period of performance or annual value thresholds are specified in the available contract documentation.
Line items
| Item | Total |
|---|---|
| RecombiMAb antimouse/human VEGF-A- 25 mg | $5,307.05 |
| Shipping & Handling (FedEx) | $84.00 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0485293?
Contract A207_PO-0485293 was awarded to Bio X Cell by University of Virginia on September 26, 2026.
How much is contract A207_PO-0485293 worth?
Its cumulative value is $5,391.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award